Multiomics – Multimedia

In this episode we speak with Tom Charlesworth and discuss how the 6-base genome can improve the understanding tumour biology from liquid biopsy.

Exploring the connections between individual omics disciplines provides us with a deeper understanding of complex biological systems.

The pandemic has ushered in a vaccines “golden era”. Long-term investment in vaccine manufacturing has been prioritized, as has the pursuit of novel vaccine platforms. In this infographic, we explore recent advances in vaccine research and development.

There is more to DNA than A, C, G and T, epigenetics plays a causal role in cell fate, aging and disease development. Genetic and methylation data together on the same read allow us to get a more complete picture of genome biology. Constrained to measuring four states of information, existing NGS- based technologies sacrifice genetic for methylation calling.

Liquid biopsy for profiling of cell free DNA (cfDNA) in blood holds huge promise to transform how we experience and manage cancer by early detection and identification of residual disease and subtype. However, a standard blood draw yields an average of only 10 ng of cfDNA, of which DNA derived from the tumor is a small minority.

In this episode we discuss how the combination of both genetic and epigenetic information within a single DNA sample can provide key insights on the dynamic interactions that are occurring, offering significant advantages in many research areas.

Speaking at ‘Advances in Proteomics & Metabolomics’ 2022, Erik Johnson from Emory University, presented their talk on proteomics in Alzheimer’s disease.

Download this listicle to learn more about high-throughput screening, mass spectrometry-based technologies, multiomics research and high-throughput drug screening.

Download this listicle to learn more about innovative solutions for high-throughput single-cell analysis and their applications within biomedical research.

Speaking at 'The Landscape of Cancer Research', Abbey Cutchin, Manager, Oncology Segment Marketing at 10x Genomics, presented her talk on cancer progression and therapeutic resistance.